Bionano Genomics, Inc.
- Nasdaq
- BNGO
- CIK
- 1411690
- Based in
- San Diego, California
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- SEC filer category
- Non-accelerated filer, Smaller reporting company
- Employer ID (EIN)
- 26-1756290
- Formerly
- BioNano Genomics, Inc, BioNanomatrix Inc
Key figures
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | $28.5M | $30.8M | $36.1M | $27.8M | $18.0M |
| Operating income | −$33.3M | −$104.0M | −$215.2M | −$131.7M | −$77.1M |
| Net income | −$26.4M | −$112.0M | −$232.5M | −$132.6M | −$72.4M |
| Diluted EPS | −$4.85 | −$88.13 | −$408.60 | −$4.58 | −$0.26 |
| Cash from operations | −$16.3M | −$68.9M | −$125.2M | −$124.8M | −$71.9M |
| Total assets | $73.6M | $76.7M | $214.4M | $307.5M | $377.1M |
| Shareholders’ equity | $44.4M | $35.4M | $96.2M | $249.4M | $337.1M |
From the company’s annual reports to the SEC. Each year links to its report.
Financials 33
- 10-Q Quarterly Report for period ending Sep 30, 2026
- 10-Q Quarterly Report for period ending Jun 30, 2026
- 10-Q Quarterly Report for period ending Mar 31, 2026
- 10-K Annual Report for period ending Dec 31, 2025
- 10-Q Quarterly Report for period ending Sep 30, 2025
- 10-Q Quarterly Report for period ending Jun 30, 2025
- 10-Q Quarterly Report for period ending Mar 31, 2025
- 10-K Annual Report for period ending Dec 31, 2024
- 10-Q Quarterly Report for period ending Sep 30, 2024
- 10-Q Quarterly Report for period ending Jun 30, 2024
News 124
Ownership 266
- SCHEDULE 13G/A Major shareholder report (passive investor)
- SCHEDULE 13G Major shareholder report (passive investor)
- 4 Luderer Albert: Change in insider ownership
- 4 Change in insider ownership
- SCHEDULE 13G/A Major shareholder report (passive investor)
- 4 Change in insider ownership
- 3 Initial statement of insider ownership
- 4 Change in insider ownership
- 3 Initial statement of insider ownership
- 4 Dixon Jonathan V.: Change in insider ownership
Prospectus 78
- 424B3 Prospectus filed pursuant to Rule 424(b)(3)
- 424B3 Prospectus filed pursuant to Rule 424(b)(3)
- S-3/A Registration statement for specified transactions by certain issuers
- S-1 General form of registration statement for all companies including face-amount certificate companies
- S-3 Registration statement for specified transactions by certain issuers
- S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
- 424B5 Prospectus filed pursuant to Rule 424(b)(5)
- 424B4 Prospectus filed pursuant to Rule 424(b)(4)
- S-1 General form of registration statement for all companies including face-amount certificate companies
- DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Proxies 40
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
- PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
- PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
Other 93
- EFFECT Notice of Effectiveness
- EFFECT Notice of Effectiveness
- ARS Annual report to security holders
- EFFECT Notice of Effectiveness
- CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
- CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
- UPLOAD Letter (PDF)
- ARS Annual report to security holders
- EFFECT Notice of Effectiveness
- CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.